Lily, Inc., a prominent player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2010, the company has rapidly established itself as a leader in innovative healthcare solutions, particularly in the fields of personalised medicine and advanced therapeutics. Lily, Inc. is renowned for its cutting-edge products, including biologics and targeted therapies, which are designed to address complex health challenges. What sets them apart is their commitment to research and development, ensuring that their offerings are not only effective but also tailored to individual patient needs. With a strong market position, Lily, Inc. has achieved significant milestones, including multiple FDA approvals and partnerships with leading research institutions, solidifying its reputation as a trusted name in the biotechnology industry.
How does Lily, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Lily, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lily, Inc., headquartered in the US, currently does not have any available carbon emissions data for the most recent year, nor does it report specific emissions figures in kg CO2e. The company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As there is no emissions data or reduction initiatives reported, it is unclear how Lily, Inc. is addressing its carbon footprint or contributing to climate action within its industry. Without specific targets or achievements, the company's climate commitments remain unspecified.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Lily, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

